Technology has made its mark everywhere. All across the
globe, newer innovations are coming up every day to make life easy, fast, and
comfortable for today’s people. And, in the process, the field of clinical
research is not left anywhere behind. Technological innovations in the clinical
research space have given rise to amazing developments in the drug development
arena. Four “smart” clinical trial programs have been developed that have
brought about significant results for the medical field, involving both medical
practitioners and patients.
Artificial
Intelligence
Ever since cognitive computing systems have been used, the
enrollment of patients into clinical trials has seen a significant increase.
The use of Artificial Intelligence has enabled valuable learning lessons in
protocol designs. Where manually processing patients can take somewhere up to 2
hours, the same number of patients can be assessed in just half an hour when
Artificial Intelligence is used! Such rapidness and intelligent usage of
technology can increase patient compliance, thus leading to incredible number
of benefits!
Blockchain based
clinical trials
Blockchain based clinical trial is a decentralized,
distributed, and public digital ledger that records transactions across
multiple computers, so that the records cannot be altered retroactively,
without altering all subsequent blocks and collusion of the network. Although
this technology has been around for a decade, it is understood only by
approximately 20% of the population. With connection to cryptocurrencies like
Bitcoin, Blockchain provides absolute source data verification across clinical
trial processes; also providing transparency and collaboration among
organizations, while preserving patient privacy.
In Silico Clinical
Trials (ISCT)
ISCT is an individualized computer simulation used in the
development or regulatory evaluation of a medicinal product, device, or
intervention. Some organizations run trials without actual patients and drugs.
Instead, they use ISCTs to analyze diverse datasets and explore alternative
study designs. These kinds of trials are useful where the population to be
tested is rare or challenging; for example, in rare diseases or where newborns
or children are required. Such trials ensure less or no wastage of resources.
Digital pills
In November 2017, the US FDA approved the world’s first
digital pill for the treatment of schizophrenia, bipolar-I disorder, and
depression. Known as Abilify MyCite, this was a tablet with a sensor embedded
in the pill, with the system including a wearable patch sensor, a smartphone
app, and web-based portals. Once ingested, the stomach’s acid activates the
sensor in the pill, which is detected and recorded by the wearable patch. This
patch then transmits the information to the app, which can be viewed via a
Web-based dashboard by selected members of the patient’s healthcare team and
family. The main aim of these digital pills is to enhance collaboration with
healthcare providers who treat patients with certain serious mental illnesses.
However, these pills are available to only a limited number of carefully
selected patients.
To
gain access to these smart clinical trial technologies and many others that are
to come, you need to get yourself into the clinical research industry as a
dedicated professional. And, to help you with that, you can have yourself
enrolled with one of the top clinicalresearch institutes in Bangalore, like Avigna Clinical Research Institute,
who has been providing the most superlative education from top professionals in
the industry, and 100% internship and placement guarantee in top CROs,
Bio-techs, and Pharmaceutical companies.
x
No comments:
Post a Comment